Technology and CAPA
Posted on April 13, 2022 by Lorenzo Sarasa
Performing corrective action and preventive action (CAPA) activities is often necessary to investigate a manufacturing deviation and prevent it from recurring. Joe O’Gorman, head of Global Operations at LZ Lifescience, a Cognizant Company spoke with and discussed the role technology plays in performing CAPAs and explores the different kinds of data that can be compiled during a CAPA, and how can these data improve product quality and the other ways that data can be used in the pharmaceutical industry.
Read the full interview here.
Comments are closed.